IL20RB
Basic information
Region (hg38): 3:136946230-137011085
Previous symbols: [ "FNDC6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL20RB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 12 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 12 | 3 | 1 |
Variants in IL20RB
This is a list of pathogenic ClinVar variants found in the IL20RB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-136948274-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
3-136948292-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
3-136948318-A-C | not specified | Uncertain significance (Nov 24, 2024) | ||
3-136948318-A-T | not specified | Uncertain significance (Jan 02, 2024) | ||
3-136948364-A-T | not specified | Uncertain significance (Dec 28, 2022) | ||
3-136948380-A-G | not specified | Uncertain significance (May 17, 2023) | ||
3-136958129-A-G | not specified | Uncertain significance (Jul 02, 2024) | ||
3-136958132-G-T | not specified | Uncertain significance (Jun 26, 2024) | ||
3-136980553-C-T | not specified | Likely benign (May 15, 2023) | ||
3-136980582-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
3-136982180-C-T | not specified | Likely benign (Jul 25, 2023) | ||
3-136982228-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
3-136982278-C-T | not specified | Uncertain significance (Sep 08, 2024) | ||
3-136982279-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
3-136982330-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
3-136982332-C-T | not specified | Uncertain significance (Oct 07, 2024) | ||
3-136989453-G-A | not specified | Uncertain significance (Apr 12, 2024) | ||
3-136989471-C-T | not specified | Uncertain significance (Sep 29, 2022) | ||
3-136989562-C-G | Benign (Apr 11, 2018) | |||
3-136991971-C-A | not specified | Uncertain significance (Feb 16, 2023) | ||
3-136991989-A-G | not specified | Uncertain significance (Jan 06, 2023) | ||
3-136991991-G-A | not specified | Uncertain significance (Sep 06, 2024) | ||
3-136992031-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
3-136995459-T-G | not specified | Uncertain significance (Jul 25, 2023) | ||
3-136995498-A-T | not specified | Uncertain significance (Oct 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL20RB | protein_coding | protein_coding | ENST00000329582 | 7 | 64856 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.65e-8 | 0.346 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.612 | 153 | 176 | 0.870 | 0.00000912 | 2028 |
Missense in Polyphen | 21 | 34.264 | 0.61289 | 422 | ||
Synonymous | 0.497 | 65 | 70.3 | 0.925 | 0.00000405 | 612 |
Loss of Function | 0.679 | 13 | 15.9 | 0.816 | 7.64e-7 | 177 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000356 | 0.000356 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000239 | 0.000237 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000105 | 0.0000980 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL22RA1/IL20RB dimer is a receptor for IL20 and IL24.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;Signaling by Interleukins;Cytokine Signaling in Immune system;Interleukin-20 family signaling;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.520
- rvis_EVS
- 0.22
- rvis_percentile_EVS
- 68.13
Haploinsufficiency Scores
- pHI
- 0.186
- hipred
- N
- hipred_score
- 0.213
- ghis
- 0.507
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.677
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il20rb
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- negative regulation of type IV hypersensitivity;inflammatory response to antigenic stimulus;immune response-inhibiting signal transduction;cytokine-mediated signaling pathway;negative regulation of interferon-gamma production;negative regulation of interleukin-2 production;positive regulation of interleukin-10 production;positive regulation of interleukin-4 production;negative regulation of T cell proliferation;homeostasis of number of cells within a tissue
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- cytokine receptor activity;protein binding;interleukin-20 binding